We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$5.97B
Cap. Flow %
-2.34%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$311M
2
EXR icon
Extra Space Storage
EXR
+$293M
3
KO icon
Coca-Cola
KO
+$246M
4
TCO
Taubman Centers Inc.
TCO
+$211M
5
NTAP icon
NetApp
NTAP
+$188M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.77%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTL
4051
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$5K ﹤0.01%
+204
New +$5.16K
RXDX
4052
DELISTED
Ignyta, Inc.
RXDX
$5K ﹤0.01%
+335
New +$4.05K
KITE
4053
DELISTED
Kite Pharma, Inc.
KITE
$5K ﹤0.01%
+88
New +$5.02K
AEGR
4054
DELISTED
Aegerion Pharmaceuticals
AEGR
$5K ﹤0.01%
+287
New +$6.21K
TBRA
4055
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$5K ﹤0.01%
+291
New +$4.25K
VTAE
4056
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$5K ﹤0.01%
+334
New +$4.54K
LDRH
4057
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$5K ﹤0.01%
+125
New +$4.97K
UNIS
4058
DELISTED
Unilife Corporation
UNIS
$5K ﹤0.01%
+232
New +$7.04K
OCAT
4059
DELISTED
OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
$5K ﹤0.01%
+1,029
New +$6.59K
ZSPH
4060
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$5K ﹤0.01%
+102
New +$5.02K
BEAT
4061
DELISTED
BioTelemetry, Inc.
BEAT
$5K ﹤0.01%
+562
New +$5.2K
CTIC
4062
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5K ﹤0.01%
+246
New +$4.75K
CYTR
4063
DELISTED
CytRx Corp
CYTR
$5K ﹤0.01%
+228
New +$5.71K
RXII
4064
DELISTED
GALENA BIOPHARMA INC COM
RXII
$5K ﹤0.01%
+2,843
New +$5K
BDSI
4065
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$5K ﹤0.01%
630
-4,195,081
-100% -$36M
OMED
4066
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$5K ﹤0.01%
+217
New +$5.35K
OSIR
4067
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$5K ﹤0.01%
+276
New +$4.88K
IMDZ
4068
DELISTED
Immune Design Corp.
IMDZ
$5K ﹤0.01%
+224
New +$5.29K
NWBO
4069
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$5K ﹤0.01%
+537
New +$4.7K
RPTP
4070
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$5K ﹤0.01%
+348
New +$4.23K
ABEO icon
4071
Abeona Therapeutics
ABEO
$369M
$4K ﹤0.01%
+32
New +$4.81K
ATLO icon
4072
AMES National
ATLO
$269M
$4K ﹤0.01%
151
-694
-82% -$17.3K
BHB icon
4073
Bar Harbor Bankshares
BHB
$660M
$4K ﹤0.01%
173
-658
-79% -$15.6K
DEA
4074
Easterly Government Properties
DEA
$1.15B
$4K ﹤0.01%
+100
New +$3.98K
DNN icon
4075
Denison Mines
DNN
$2.64B
$4K ﹤0.01%
+5,105
New +$4.31K

Similar funds

Invesco's Q2 2015 Portfolio in Review

As of Q2 2015, Invesco held 4,482 positions worth $255B, down 1.4% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Invesco's Q2 2015 filing shows 462 new, 1,845 increased, 1,866 reduced and 145 closed positions. Its largest new stake was Anthem, Inc.: 1,170,000 shares worth $61.6M. The largest sale was Fiat Chrysler Automobiles N.V., an estimated $3.11B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2015 buy was Anthem, Inc.: 1,170,000 shares worth $61.6M.
  • Invesco added most to Equinix in Q2 2015, an estimated $311M increase.
  • Invesco's biggest Q2 2015 reduction was Fiat Chrysler Automobiles N.V., cutting an estimated $3.11B.
  • Invesco fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $126M.
  • Invesco's ten largest holdings make up 13% of its $255B portfolio in Q2 2015.
  • Invesco opened 462 new positions and closed 145 in Q2 2015.
  • Invesco's portfolio value fell 1.4% quarter-over-quarter to $255B.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.